| Literature DB >> 33180995 |
Diana Molino1, Irene Pila-Castellanos1,2, Henri-Baptiste Marjault3, Nivea Dias Amoedo4, Katja Kopp5, Leila Rochin6, Ola Karmi3, Yang-Sung Sohn3, Laetitia Lines2, Ahmed Hamaï1, Stéphane Joly2, Pauline Radreau2, Jacky Vonderscher2, Patrice Codogno1, Francesca Giordano6, Peter Machin2, Rodrigue Rossignol4,7, Eric Meldrum2, Damien Arnoult8, Alessia Ruggieri5, Rachel Nechushtai3, Benoit de Chassey2, Etienne Morel1.
Abstract
Several human pathologies including neurological, cardiac, infectious, cancerous, and metabolic diseases have been associated with altered mitochondria morphodynamics. Here, we identify a small organic molecule, which we named Mito-C. Mito-C is targeted to mitochondria and rapidly provokes mitochondrial network fragmentation. Biochemical analyses reveal that Mito-C is a member of a new class of heterocyclic compounds that target the NEET protein family, previously reported to regulate mitochondrial iron and ROS homeostasis. One of the NEET proteins, NAF-1, is identified as an important regulator of mitochondria morphodynamics that facilitates recruitment of DRP1 to the ER-mitochondria interface. Consistent with the observation that certain viruses modulate mitochondrial morphogenesis as a necessary part of their replication cycle, Mito-C counteracts dengue virus-induced mitochondrial network hyperfusion and represses viral replication. The newly identified chemical class including Mito-C is of therapeutic relevance for pathologies where altered mitochondria dynamics is part of disease etiology and NEET proteins are highlighted as important therapeutic targets in anti-viral research.Entities:
Keywords: NEET proteins; contact sites; mitochondria; morphodynamics; virus
Mesh:
Substances:
Year: 2020 PMID: 33180995 PMCID: PMC7726809 DOI: 10.15252/embr.201949019
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 9.071